Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 3-[[[(1R)-1-phenylethyl]amino]carbonyl]-5-(tetrahydro-1,1-dioxido-2H-1, 2-thiazin-2-yl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

911790-38-0

Post Buying Request

911790-38-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

911790-38-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 911790-38-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,1,7,9 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 911790-38:
(8*9)+(7*1)+(6*1)+(5*7)+(4*9)+(3*0)+(2*3)+(1*8)=170
170 % 10 = 0
So 911790-38-0 is a valid CAS Registry Number.

911790-38-0Upstream product

911790-38-0Downstream Products

911790-38-0Relevant academic research and scientific papers

BACE-2 INHIBITORY COMPOUNDS AND RELATED METHODS OF USE

-

Paragraph 0140; 0144; 0164; 0166, (2017/05/02)

Provided herein are novel compounds of Formulae I-III, and methods of using the same to selectively inhibit BACE2.

Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors

Chirapu, Srinivas Reddy,Pachaiyappan, Boobalan,Nural, Hikmet F.,Cheng, Xin,Yuan, Hongbin,Lankin, David C.,Abdul-Hay, Samer O.,Thatcher, Gregory R.J.,Shen, Yong,Kozikowski, Alan P.,Petukhov, Pavel A.

scheme or table, p. 264 - 274 (2009/05/26)

A series of transition state analogues of beta-secretases 1 and 2 (BACE1, 2) inhibitors containing fused-ring or biaryl moieties were designed computationally to probe the S2 pocket, synthesized, and tested for BACE1 and BACE2 inhibitory activity. It has

Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof

-

Page/Page column 223, (2010/11/24)

The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 911790-38-0